Stay updated with breaking news from Beck Bode. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Core Laboratories (NYSE:CLB – Get Rating) had its price target hoisted by Piper Sandler from $18.00 to $19.00 in a research note issued to investors on Monday, The Fly reports. CLB has been the topic of a number of other reports. Bank of America cut Core Laboratories from a neutral rating to an underperform rating […]
Beck Bode LLC lowered its position in shares of ProShares Short QQQ (NYSEARCA:PSQ – Get Rating) by 93.3% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 11,599 shares of the company’s stock after selling 161,035 shares during the period. Beck Bode LLC’s holdings in ProShares Short QQQ were worth $171,000 at the end […]
Beck Bode LLC lessened its holdings in Norfolk Southern Co. (NYSE:NSC – Get Rating) by 75.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,552 shares of the railroad operator’s stock after selling 8,042 shares during the period. Beck Bode LLC’s […]
C3.ai, Inc. (NYSE:AI – Get Rating) CFO Juho Parkkinen sold 4,438 shares of C3.ai stock in a transaction that occurred on Monday, May 1st. The stock was sold at an average price of $18.11, for a total value of $80,372.18. Following the completion of the transaction, the chief financial officer now directly owns 336,971 shares […]
Beck Bode LLC purchased a new position in shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Rating) in the 4th quarter, HoldingsChannel.com reports. The fund purchased 27,226 shares of the biopharmaceutical company’s stock, valued at approximately $42,000. Several other hedge funds have also added to or reduced their stakes in INO. MetLife Investment Management LLC […]